Daily BriefsSouth Korea

Daily Brief South Korea: Celltrion Pharm, Fila Holdings and more

In today’s briefing:

  • Targeting Spreads by Leveraging the High Predictability of the Celltrion Merger
  • Block Deal Sale of About 98 Billion Won Worth of Acushnet Holdings by Fila Holdings


Targeting Spreads by Leveraging the High Predictability of the Celltrion Merger

By Sanghyun Park

  • Local market views Celltrion’s shareholder survey as the start of the merger process, with a decision expected from the boards within two to three months if there’s no major opposition.
  • Under Korean law, if Celltrion Pharm’s market cap is under one-tenth of Celltrion’s, the merger can proceed as a small-scale merger, allowing Celltrion to avoid shareholder approval and appraisal rights.
  • We should leverage the merger’s high predictability to proactively target merger swap and appraisal rights spreads and build a strategy in advance.

Block Deal Sale of About 98 Billion Won Worth of Acushnet Holdings by Fila Holdings

By Douglas Kim

  • Fila Holdings announced that its subsidiary Magnus Holdings plans to sell a 1.8% stake in Acushnet Holdings in a block deal sale worth about 98 billion won. 
  • Our NAV valuation of Fila Holdings suggests an implied value per share of 49,192 won, representing 18.2% upside from current levels. Fila Holdings’ 51.9% stake in Acushnet Holdings.
  • The block deal sale of Acushnet Holdings by Magnus Holdings is likely to have a positive impact on Fila Holdings as it could result in higher capital returns to shareholders.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars